Opko Health Stock Current Valuation
| OPK Stock | USD 1.58 0.02 1.28% |
Valuation analysis of Opko Health helps investors to measure Opko Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is expected to rise to about 1.5 B this year, although Enterprise Value Over EBITDA is projected to rise to (19.81). Fundamental drivers impacting Opko Health's valuation include:
Price Book 0.7575 | Enterprise Value 1.2 B | Enterprise Value Ebitda 61.6627 | Price Sales 1.4943 | Forward PE 64.5161 |
Undervalued
Today
Please note that Opko Health's price fluctuation is unstable at this time. Calculation of the real value of Opko Health is based on 3 months time horizon. Increasing Opko Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Opko Health's intrinsic value may or may not be the same as its current market price of 1.58, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.58 | Real 2.3 | Target 4.48 | Hype 1.58 | Naive 1.56 |
The intrinsic value of Opko Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Opko Health's stock price.
Estimating the potential upside or downside of Opko Health helps investors to forecast how Opko stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Opko Health more accurately as focusing exclusively on Opko Health's fundamentals will not take into account other important factors: Opko Health Company Current Valuation Analysis
Opko Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Opko Health Current Valuation | 1.17 B |
Most of Opko Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Opko Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Opko Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Opko Health is extremely important. It helps to project a fair market value of Opko Stock properly, considering its historical fundamentals such as Current Valuation. Since Opko Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Opko Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Opko Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Opko Current Valuation Historical Pattern
Today, most investors in Opko Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Opko Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Opko Health current valuation as a starting point in their analysis.
Opko Health Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Opko Health has a Current Valuation of 1.17 B. This is 91.86% lower than that of the Biotechnology sector and 85.01% lower than that of the Health Care industry. The current valuation for all United States stocks is 92.97% higher than that of the company.
Opko Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Opko Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Opko Health could also be used in its relative valuation, which is a method of valuing Opko Health by comparing valuation metrics of similar companies.Opko Health is currently under evaluation in current valuation category among its peers.
Opko Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Opko Health from analyzing Opko Health's financial statements. These drivers represent accounts that assess Opko Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Opko Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 875.3M | 2.5B | 3.1B | 898.8M | 1.1B | 1.4B | |
| Enterprise Value | 1.0B | 2.7B | 3.2B | 959.1M | 1.4B | 1.5B |
Opko Fundamentals
| Return On Equity | -0.0939 | ||||
| Return On Asset | -0.0897 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.62) % | ||||
| Current Valuation | 1.17 B | ||||
| Shares Outstanding | 672.8 M | ||||
| Shares Owned By Insiders | 54.45 % | ||||
| Shares Owned By Institutions | 28.02 % | ||||
| Number Of Shares Shorted | 95.86 M | ||||
| Price To Earning | 7.46 X | ||||
| Price To Book | 0.76 X | ||||
| Price To Sales | 1.49 X | ||||
| Revenue | 863.5 M | ||||
| Gross Profit | 214.3 M | ||||
| EBITDA | (65.52 M) | ||||
| Net Income | (188.86 M) | ||||
| Cash And Equivalents | 210.46 M | ||||
| Cash Per Share | 0.27 X | ||||
| Total Debt | 326.56 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 2.06 X | ||||
| Cash Flow From Operations | (28.2 M) | ||||
| Short Ratio | 33.99 X | ||||
| Earnings Per Share | (0.19) X | ||||
| Price To Earnings To Growth | (2.87) X | ||||
| Target Price | 3.96 | ||||
| Number Of Employees | 3.93 K | ||||
| Beta | 1.65 | ||||
| Market Capitalization | 1.06 B | ||||
| Total Asset | 2.01 B | ||||
| Retained Earnings | (2.01 B) | ||||
| Working Capital | 109.42 M | ||||
| Current Asset | 454.06 M | ||||
| Current Liabilities | 251.9 M | ||||
| Net Asset | 2.01 B |
About Opko Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Opko Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Opko Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Opko Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Opko Health Piotroski F Score and Opko Health Altman Z Score analysis. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.19) | Revenue Per Share 0.998 | Quarterly Revenue Growth (0.03) | Return On Assets (0.09) |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.